Pharmaceutical Packaging Market

Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled Syringes), Drug Delivery, and Region - Global Forecast to 2028

Report Code: CH 3482 Jan, 2024, by marketsandmarkets.com

The global pharmaceutical packaging market size is estimated to be USD 132.0 billion in 2023 and projected to reach USD 269.9 billion in 2028, at a CAGR of 15.4%. The market growth is driven by increasing concerns about chronic diseases, driving the demand for packaging that ensures product integrity and minimizes contamination risks. The growing demand for drug delivery devices and blister packaging also plays a pivotal role in propelling the pharmaceutical packaging market.

Opportunities in the Pharmaceutical Packaging Market

Pharmaceutical Packaging Market

To know about the assumptions considered for the study, Request for Free Sample Report

Pharmaceutical Packaging Market

Recession Impact

The packaging sector has proven to be resilient through challenging economic environments, such as the Great Recession and the COVID-19 pandemic. However, packaging companies achieved EBITDA growth rates in line with or better than the broader market during these periods, with greater stability and resilience as demonstrated by lower peak-to-trough declines. In the pharmaceutical industry, the predictions for a recession are not nearly as dire but are still high. In the wider economy, recession fears have been sparked by indicators such as the US government's deficit and trade tensions with China. To some extent, the pharmaceutical industry is shielded from these issues. While there may be a general recession, the demand for life-saving medications is not going to change. Yet, these wider economic jitters are now colliding with downward pricing pressures within the pharmaceuticals industry and prompting companies to retool many of their efforts in R&D and their pricing models.

Pharmaceutical Packaging Market Dynamics

Driver: Growing healthcare expenditure and the pharmaceuticals industry in emerging economies drive the market

The pharmaceutical industry is experiencing rapid expansion in emerging economies, fueled by technological innovations, advanced manufacturing processes, and enhanced collaboration among companies. This growth is driving the pharmaceutical packaging market, with the most significant impact expected in emerging economies such as Russia, Brazil, India, and China. Factors such as increased awareness of the benefits of robust healthcare systems, rising income levels, and a focus on healthier lifestyles are contributing to market growth in these regions. Additionally, demographic trends and the large population base, including a growing young population and higher life expectancy, serve as key drivers for this growth.

Restrain: Lack of access to proper healthcare in emerging economies.

The growth of the market is hindered by factors such as poverty, inadequate infrastructure, low literacy rates, and the presence of unorganized healthcare systems in emerging economies. In India, a significant portion of the population continues to face challenges due to subpar healthcare quality and limited access. Poverty stands out as a significant obstacle to obtaining healthcare services in these emerging economies. Financial constraints, lack of information, outdated equipment, lack of proper staff, and awareness of proper healthcare practices are the major challenges that limit access to healthcare services. These issues are restraining the growth of the pharmaceutical packaging market in India, Brazil, South Africa, and other emerging economies.

Opportunity: Growing demand for primary pharmaceutical packaging

Primary pharmaceutical packaging products come in direct contact with the medicine or drug. These products encompass a range of items, including glass bottles, plastic bottles, prefilled syringes, medication tubes, prefilled inhalers, blister packaging, and more. The primary contributors to the growth of this segment are prefillable syringes and prefilled inhalers, with blister packs, plastic bottles, and ampoules & vials also experiencing significant growth. The expansion of diverse and advanced drug-producing companies in emerging economies such as the US, France, Canada, Japan, Germany, and the UK, along with the adoption of advanced packaging technologies such as eco-friendly packaging, patient-specific dosages,  and innovative counterfeiting techniques, will propel the growth of primary packaging.

Challenge: Protecting against counterfeit products

The extended timelines and costs associated with the approval of new drugs and their packaging contribute to delays, leading to a rise in counterfeit drugs and fake packaging. These counterfeit products pose health risks, including allergic reactions, nausea, and vomiting. Emerging technologies like induction seals, near-field communication (NFC) tags, nano barcodes, serialization, cloud, and blockchain offer improved counterfeit protection and enhance distribution traceability. However, counterfeiters often find ways to bypass these systems within two to three years, necessitating frequent and costly upgrades for pharmaceutical packaging companies. Hence, fighting the counterfeiting of products is a major challenge for pharmaceutical packaging companies.

Pharmaceutical Packaging Market: Ecosystem

Pharmaceutical Packaging Market Ecosystem

The pre-filled syringes segment is the fastest growing type in the pharmaceutical packaging market during the forecast period.

Pre-filled syringes are highly regarded by healthcare professionals as an effective, dependable, and convenient means of drug administration. They are acknowledged for their ability to reduce drug waste, extend product shelf life, and enhance market share. Additionally, pre-filled syringes offer benefits such as minimizing the risk of contamination, preventing drug wastage due to overfilling, eliminating dosing errors, and enabling rapid drug delivery during emergencies. These are some factors driving demand for pre-filled syringes in the pharmaceutical packaging market.

Primary packaging is the fastest growing packaging type in the pharmaceutical packaging market during the forecast period.

The primary packaging market in the pharmaceutical packaging industry is rapidly expanding due to several significant factors. These include the global growth of the pharmaceutical industry, which is being driven by increasing healthcare needs, population expansion, and the prevalence of chronic diseases. Additionally, the demand for primary pharmaceutical packaging materials and solutions is on the rise due to stringent regulatory requirements set by organizations such as the FDA and EMA, which ensure product safety and traceability. Furthermore, the globalization of the pharmaceutical supply chain is increasing the need for packaging materials that can withstand international shipping and maintain product integrity.

Injectables are the fastest growing drug delivery in the pharmaceutical packaging market during the forecast period.

Injectable drug delivery modes are recognized as highly effective and successful routes of drug administration due to their rapid and efficient delivery to the target area. While most drugs are administered orally or through injections, injectables come in various forms such as self-injection devices, prefilled syringes, auto-injectors, safety syringes, patch injectors, pen injectors, and more. Technological advancements have led to the creation of a diverse range of improved and enhanced devices.

Plastic is the fastest growing raw material in the pharmaceutical packaging market during the forecast period.

Plastics are permeable to moisture, oxygen, and carbon dioxide, and they allow the penetration of light rays unless the plastic container is pigmented. The pharmaceutical industry is increasingly exploring sustainable and recyclable packaging materials to reduce waste and improve environmental impact. The market for this segment is driven by the wide use of plastics in OTC drugs, blister packaging, prefilled syringes, and the oral drug delivery mode.

Asia Pacific is the fastest growing in the pharmaceutical packaging market, in terms of value.

Asia Pacific stands as the fastest-growing region in the pharmaceutical packaging market due to the rising population and increasing adoption of advanced technologies. The recent trends reflecting improved healthcare systems and enhanced access to healthcare services in the region present new growth opportunities for pharmaceutical packaging providers. The emerging markets within the Asia Pacific region are poised to experience rapid growth in the coming years, driven by factors such as increasing government initiatives, evolving lifestyles, expanding contract manufacturing activities, and an aging demographic.

Pharmaceutical Packaging Market by Region

Source: Secondary Research, Primary Interviews, and MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Berry Global (US), Gerresheimer AG (Germany), Amcor plc (Switzerland), Schott AG (Germany), and AptarGroup, Inc. (US) are some of the established players in the pharmaceutical packaging market. These players have established a strong foothold in the market by adopting strategies, such as expansions, joint ventures, and mergers & acquisitions.

Read More: Pharmaceutical Packaging Companies

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Years considered for the study

2020–2028

Base year considered

 2022

Forecast period

2023–2028

Units considered

Value (USD)

Segments

Type, Packaging Type, Drug Delivery, Raw Material, and Region

Regions

North America, APAC, Europe, Middle East & Africa, and South America

Companies

Berry Global (US), Amcor Plc (Europe), Gerresheimer AG (Europe),  Schott AG (Europe) and  AptarGroup (US)
25 major players covered.

The study categorizes the pharmaceutical packaging market based on type, raw material, packaging type, drug delivery, and region.

By Type:
  • Plastic Bottles
  • Blister Packs
  • Caps & Closures
  • Pre-filled Syringes
  • Pouches & Strips
  • Pre-filled Inhalers
  • Vials
  • Ampoules
  • Cartridges
  • Labels & Accessories
  • Medical Specialty Bags
  • Temperature-controlled Packaging
  • Medication Tubes
  • Jars & Canisters
  • Others
By Drug Delivery:
  • Oral Drugs
  • Pulmonary
  • Transdermal
  • Injectables
  • Topical
  • Nasal
  • Ocular/Ophthalmic
  • IV Drugs
  • Others
By Packaging Type
  • Primary
  • Secondary
By Raw Material
  • Plastics
  • Paper & paperboard
  • Glass
  • Metal
  • Others
By Region:
  • North America
  • Asia Pacific
  • Europe
  • Middle East & Africa
  • South America

Recent Developments

  • In June 2022, Becton, Dickinson and Company acquired Parata Systems. This strategic acquisition enables the company to venture into new pharmacy automation solutions aimed at reducing costs, enhancing patient safety, and improving the overall patient experience. It bolsters the company's pharmacy automation portfolio by incorporating high-speed robotic dispensing technologies, medication adherence packaging, and pharmacy workflow solutions.
  • In November 2022, Amcor investment in PulPac fiber technology, a Swedish company providing disruptive manufacturing technology for low-cost, high-performance fiber-based packaging.
  • In November 2022, Aptar Pharma collaborated with TFF Pharmaceuticals. The collaboration focuses on the development and testing of dry powder vaccines administration using TFF Pharmaceutical's Thin Film Freezing technology and Aptar Pharma's proprietary intranasal Unidose (UDS) powder nasal spray system.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 39)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 INCLUSIONS & EXCLUSIONS 
          TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS
    1.4 STUDY SCOPE 
          FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
           1.4.1 REGIONS COVERED
                    FIGURE 2 REGIONAL SCOPE
           1.4.2 YEARS CONSIDERED
    1.5 CURRENCY CONSIDERED 
    1.6 UNITS CONSIDERED 
    1.7 STAKEHOLDERS 
    1.8 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 44)
    2.1 RESEARCH DATA 
          FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key secondary sources
                    2.1.1.2 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key primary sources
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Key industry insights
                    2.1.2.4 Breakdown of primary interviews
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
                    FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION 
          FIGURE 6 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
           2.3.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY SOURCES
           2.3.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES
                    FIGURE 7 PHARMACEUTICAL PACKAGING MARKET ANALYSIS
    2.4 RESEARCH ASSUMPTIONS 
    2.5 FACTOR ANALYSIS 
    2.6 GROWTH ESTIMATION 
           2.6.1 SUPPLY SIDE
           2.6.2 DEMAND SIDE
    2.7 LIMITATIONS & RISKS 
    2.8 RECESSION IMPACT 
 
3 EXECUTIVE SUMMARY (Page No. - 55)
    FIGURE 8 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
    FIGURE 9 PLASTICS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
    FIGURE 10 ORAL DRUG DELIVERY MODE TO DOMINATE MARKET DURING FORECAST PERIOD
    FIGURE 11 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
    FIGURE 12 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
 
4 PREMIUM INSIGHTS (Page No. - 60)
    4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET 
          FIGURE 13 ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
    4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 
          FIGURE 14 PREFILLED SYRINGES TO RECORD FASTEST GROWTH DURING 
          FORECAST PERIOD 61
    4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 
          FIGURE 15 PLASTICS SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
    4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY 
          FIGURE 16 INJECTABLES SEGMENT TO BE FASTEST-GROWING MARKET BY 2028
    4.5 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE 
          FIGURE 17 PRIMARY SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
    4.6 PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY 
          FIGURE 18 INDIA TO DOMINATE MARKET DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 64)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Surge in healthcare expenditure and growth of pharmaceutical industry
                    5.2.1.2 Rising demand for drug delivery devices and blister packaging
                    5.2.1.3 Technological advancements in pharmaceutical packaging
                               5.2.1.3.1 Nanomedicine and nano drug delivery systems
                               5.2.1.3.2 Child-resistant packaging
                               5.2.1.3.3 Radio-frequency identification
                               5.2.1.3.4 Micro-pump technology
                               5.2.1.3.5 Eco-friendly and sustainable packaging
           5.2.2 RESTRAINTS
                    5.2.2.1 Surge in packaging costs due to dynamic regulatory policies
                    5.2.2.2 Restricted access to healthcare systems in emerging economies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for primary pharmaceutical packaging
           5.2.4 CHALLENGES
                    5.2.4.1 Safeguarding against counterfeit products
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
           5.3.1 RAW MATERIAL SUPPLIERS
           5.3.2 R&D OF PRODUCTS
           5.3.3 MANUFACTURERS
           5.3.4 DISTRIBUTORS
           5.3.5 END USERS
    5.4 PORTER’S FIVE FORCES ANALYSIS 
           FIGURE 21 PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET
           5.4.1 THREAT OF NEW ENTRANTS
           5.4.2 THREAT OF SUBSTITUTES
           5.4.3 BARGAINING POWER OF BUYERS
           5.4.4 BARGAINING POWER OF SUPPLIERS
           5.4.5 INTENSITY OF COMPETITIVE RIVALRY
                    TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET
    5.5 MACROECONOMIC INDICATORS 
           5.5.1 GLOBAL GDP TRENDS
                    TABLE 3 TRENDS OF PER CAPITA GDP (USD), 2019–2021
                    TABLE 4 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027
                    TABLE 5 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2020
    5.6 TARIFF & REGULATORY LANDSCAPE 
           5.6.1 REGULATIONS
                    5.6.1.1 Europe
                    5.6.1.2 US
                    5.6.1.3 Others
           5.6.2 STANDARDS
                    5.6.2.1 ISO 9001
                    5.6.2.2 ISO 22000
                    5.6.2.3 ASTM D3475
                    5.6.2.4 USP (United States Pharmacopeia) Standards
                    5.6.2.5 Child-resistant Packaging Standards
           5.6.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.7 TECHNOLOGY ANALYSIS 
           5.7.1 NANOTECHNOLOGY
           5.7.2 PACKAGING FOR BIOLOGICS
           5.7.3 SMART PACKAGING
           5.7.4 ANTI-COUNTERFEIT PACKAGING
           5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES
    5.8 PRICING ANALYSIS 
           5.8.1 AVERAGE SELLING PRICE, BY REGION
                     FIGURE 22 AVERAGE SELLING PRICE, BY REGION (USD/KG)
           5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL
                     TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG)
    5.9 ECOSYSTEM/MARKET MAP 
          FIGURE 23 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
          TABLE 8 PHARMACEUTICAL PACKAGING MARKET: ROLE IN ECOSYSTEM
    5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
           FIGURE 24 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE FUTURE GROWTH
    5.11 PATENT ANALYSIS 
           5.11.1 INTRODUCTION
           5.11.2 METHODOLOGY
           5.11.3 DOCUMENT TYPES
                     FIGURE 25 PATENTS REGISTERED (2012–2022)
           5.11.4 PUBLICATION TRENDS
                     FIGURE 26 NUMBER OF PATENTS IN LAST 10 YEARS, 2012–2022
           5.11.5 INSIGHTS
           5.11.6 JURISDICTION ANALYSIS
                     FIGURE 27 TOP JURISDICTIONS
           5.11.7 TOP APPLICANTS
                     FIGURE 28 TOP 10 PATENT APPLICANTS
                     TABLE 9 PATENTS BY SANOFI
                     TABLE 10 PATENTS BY SCHOTT AG
                     TABLE 11 PATENTS BY NOVARTIS AG
                     FIGURE 29 TOP 10 PATENT OWNERS
                     TABLE 12 TOP 10 PATENT OWNERS IN LAST 10 YEARS
    5.12 RAW MATERIAL ANALYSIS 
           5.12.1 PLASTICS
           5.12.2 PAPER
           5.12.3 GLASS
           5.12.4 METALS
    5.13 TRADE ANALYSIS 
           5.13.1 IMPORT SCENARIO
                     TABLE 13 REGION-WISE IMPORT TRADE (USD MILLION)
                     FIGURE 30 REGION-WISE IMPORT TRADE (USD MILLION)
           5.13.2 EXPORT SCENARIO
                     TABLE 14 REGION-WISE EXPORT TRADE (USD MILLION)
                     FIGURE 31 REGION-WISE EXPORT TRADE (USD MILLION)
    5.14 KEY CONFERENCES & EVENTS IN 2024–2025 
            TABLE 15 KEY CONFERENCES & EVENTS IN 2023–2024
    5.15 CASE STUDY ANALYSIS 
           5.15.1 MOISTURE BARRIER TECHNOLOGY FOR EFFICIENT DRUG DELIVERY
           5.15.2 CUSTOM METERING VALVE FOR INHALERS
    5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE DRUG DELIVERY MODES
           5.16.2 BUYING CRITERIA
                    5.16.2.1 Quality
                    5.16.2.2 Service
                                 FIGURE 32 SUPPLIER SELECTION CRITERION
 
6 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE (Page No. - 98)
    6.1 INTRODUCTION 
          FIGURE 33 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
          TABLE 17 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
          TABLE 18 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
    6.2 PRIMARY 
           6.2.1 INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY SYSTEMS TO DRIVE MARKET
    6.3 SECONDARY 
           6.3.1 RISING ADOPTION OF PREFILLED CONTAINERS AND DELIVERY DEVICES TO FUEL DEMAND
 
7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL (Page No. - 101)
    7.1 INTRODUCTION 
          FIGURE 34 PLASTICS TO DOMINATE MARKET DURING FORECAST PERIOD
          TABLE 19 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
          TABLE 20 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
          TABLE 21 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
          TABLE 22 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
          TABLE 23 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
    7.2 PLASTIC 
           7.2.1 EFFECTIVE BARRIER PROPERTIES AND COST REDUCTION TO DRIVE MARKET
                    TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
           7.2.2 HIGH-DENSITY POLYETHYLENE
           7.2.3 POLYESTER
           7.2.4 POLYPROPYLENE
           7.2.5 LOW-DENSITY POLYETHYLENE
           7.2.6 POLYVINYL CHLORIDE
           7.2.7 CYCLIC OLEFIN COPOLYMER
           7.2.8 POLYETHYLENE TEREPHTHALATE
    7.3 PAPER & PAPERBOARD 
           7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET
                    TABLE 26 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 27 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    7.4 GLASS 
           7.4.1 CHEMICAL RESISTANCE AND STURDINESS TO BOOST DEMAND
                    TABLE 28 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 29 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
                    TABLE 30 GLASS PACKAGING TYPES
    7.5 METALS 
           7.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET
                    TABLE 31 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 32 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    7.6 OTHER RAW MATERIALS 
          TABLE 33 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
          TABLE 34 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
 
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY (Page No. - 113)
    8.1 INTRODUCTION 
          FIGURE 35 ORAL DRUG DELIVERY ACCOUNTED FOR LARGEST SHARE IN 2023
          TABLE 35 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
          TABLE 36 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
          TABLE 37 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
          TABLE 38 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
    8.2 ORAL 
           8.2.1 ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET
                    TABLE 39 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 40 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    8.3 PULMONARY 
           8.3.1 INCREASING CASES OF LUNG DISORDERS TO DRIVE MARKET
                    TABLE 41 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 42 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    8.4 TRANSDERMAL 
           8.4.1 SURGING DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET
                    TABLE 43 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 44 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    8.5 INJEC                    TABLE 
           8.5.1 INCREASING USE OF BIOLOGICS TO BOOST MARKET
                    TABLE 45 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 46 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    8.6 TOPICAL 
           8.6.1 RISING PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS
                    TABLE 47 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 48 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    8.7 NASAL 
           8.7.1 RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS
                    TABLE 49 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 50 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    8.8 OCULAR/OPHTHALMIC 
           8.8.1 INCREASING FREQUENCY OF OPTHALMIC DISEASES TO DRIVE MARKET
                    TABLE 51 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 52 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    8.9 INTRAVENOUS 
           8.9.1 HIGH OCCURENCE OF CHRONIC DISEASES TO FUEL MARKET
                    TABLE 53 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                    TABLE 54 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    8.10 OTHER DRUG DELIVERY MODES 
           TABLE 55 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
           TABLE 56 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
 
9 PHARMACEUTICAL PACKAGING MARKET, BY TYPE (Page No. - 126)
    9.1 INTRODUCTION 
          FIGURE 36 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
          TABLE 57 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
          TABLE 58 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
    9.2 PLASTIC BOTTLES 
           9.2.1 EXTENSIVE USE IN PACKAGING ORAL DRUGS TO BOOST MARKET
                     TABLE 59 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 60 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
           9.2.2 STANDARD PLASTIC BOTTLES
           9.2.3 PLASTIC DISPENSING BOTTLES
           9.2.4 PLASTIC JARS
    9.3 BLISTER PACKS 
           9.3.1 ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET
                     TABLE 61 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 62 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
           9.3.2 COMPARTMENT PACKS
           9.3.3 WALLET PACKS
    9.4 LABELS & ACCESSORIES 
           9.4.1 NEED FOR STRINGENT GUIDELINES ON DRUG INSTRUCTIONS TO FUEL DEMAND
                     TABLE 63 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 64 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
           9.4.2 SELF ADHESIVE
           9.4.3 DIE CUT
           9.4.4 HOLOGRAPHIC STRIPS
           9.4.5 TAMPER PROOF
           9.4.6 OTHER LABELS
    9.5 CAPS & CLOSURES 
           9.5.1 DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING TO FUEL MARKET
                     TABLE 65 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 66 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.6 MEDICAL SPECIALTY BAGS 
           9.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND
                     TABLE 67 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 68 MEDICAL SPECIALTY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.7 PREFILLED SYRINGES 
           9.7.1 RISING NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS TO BOOST MARKET
                     TABLE 69 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 70 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.8 TEMPERATURE-CONTROLLED PACKAGING 
           9.8.1 SURGING DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND VACCINES TO FUEL MARKET
                     TABLE 71 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 72 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.9 POUCHES & STRIP PACKS 
           9.9.1 INCREASING DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET
                     TABLE 73 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 74 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.10 AMPOULES 
           9.10.1 HIGH REQUIREMENT FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET
                     TABLE 75 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 76 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.11 VIALS 
           9.11.1 CONSISTENT DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE MARKET
                     TABLE 77 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 78 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.12 PREFILLED INHALERS 
           9.12.1 HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET
                     TABLE 79 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 80 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
           9.12.2 METERED DOSE INHALERS
           9.12.3 DRY POWDER INHALERS
    9.13 MEDICATION TUBES 
           9.13.1 INCREASING DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET
                     TABLE 81 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 82 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
           9.13.2 COMPOSITE TUBES
           9.13.3 ALL-PLASTIC TUBES
           9.13.4 COLLAPSIBLE METAL TUBES
    9.14 JARS & CANISTERS 
           9.14.1 EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS
                     TABLE 83 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 84 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.15 CARTRIDGES 
           9.15.1 INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET
                     TABLE 85 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
                     TABLE 86 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.16 OTHER TYPES 
           TABLE 87 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
           TABLE 88 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
 
10 PHARMACEUTICAL PACKAGING MARKET, BY REGION (Page No. - 148)
     10.1 INTRODUCTION 
             FIGURE 37 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
             TABLE 89 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
             TABLE 90 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             10.2.1 RECESSION IMPACT
                        FIGURE 38 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
                        TABLE 91 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
                        TABLE 92 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
                        TABLE 93 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 94 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
                        TABLE 95 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
                        TABLE 96 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
                        TABLE 97 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
                        TABLE 98 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
                        TABLE 99 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
                        TABLE 100 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
                        TABLE 101 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
                        TABLE 102 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
             10.2.2 US
                        10.2.2.1 Rapid technological advancements in pharmaceutical packaging to drive market
                                      TABLE 103 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 104 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Competitive business environment to boost market
                                      TABLE 105 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 106 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.2.4 MEXICO
                        10.2.4.1 Government initiatives in healthcare industry to fuel demand for pharmaceutical products
                                      TABLE 107 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 108 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
     10.3 EUROPE 
             10.3.1 RECESSION IMPACT
                        FIGURE 39 EUROPE: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
                        TABLE 109 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
                        TABLE 110 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
                        TABLE 111 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 112 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
                        TABLE 113 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
                        TABLE 114 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
                        TABLE 115 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
                        TABLE 116 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
                        TABLE 117 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
                        TABLE 118 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
                        TABLE 119 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
                        TABLE 120 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
             10.3.2 GERMANY
                        10.3.2.1 Increase in aging population and noncommunicable diseases to drive market
                                      TABLE 121 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 122 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 High demand for generic drugs to drive market
                                      TABLE 123 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 124 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Rising exports of pharmaceutical products to boost market
                                      TABLE 125 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 126 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.3.5 UK
                        10.3.5.1 Innovations in drug manufacturing to drive market
                                      TABLE 127 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 128 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Government initiatives in healthcare sector to boost demand
                                      TABLE 129 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 130 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.3.7 RUSSIA
                        10.3.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market
                                      TABLE 131 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 132 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.3.8 REST OF EUROPE
                        TABLE 133 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 134 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
     10.4 ASIA PACIFIC 
             10.4.1 RECESSION IMPACT
                        FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
                        TABLE 135 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
                        TABLE 136 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
                        TABLE 137 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 138 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
                        TABLE 139 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
                        TABLE 140 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
                        TABLE 141 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
                        TABLE 142 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
                        TABLE 143 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
                        TABLE 144 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
                        TABLE 145 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
                        TABLE 146 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
             10.4.2 CHINA
                        10.4.2.1 Increased investments in biologics and biosimilar drug research to drive market
                                      TABLE 147 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 148 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Rise in aging population to drive demand for medications
                                      TABLE 149 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 150 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.4.4 SOUTH KOREA
                        10.4.4.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers to drive market
                                      TABLE 151 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 152 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.4.5 INDIA
                        10.4.5.1 Large domestic consumption and export of generic drugs to drive market
                                      TABLE 153 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 154 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.4.6 AUSTRALIA
                        10.4.6.1 Wide adoption of Medicare and PBS schemes to drive market
                                      TABLE 155 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 156 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.4.7 REST OF ASIA PACIFIC
                        TABLE 157 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 158 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
     10.5 SOUTH AMERICA 
             10.5.1 RECESSION IMPACT
                        TABLE 159 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
                        TABLE 160 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
                        TABLE 161 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 162 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
                        TABLE 163 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
                        TABLE 164 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
                        TABLE 165 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
                        TABLE 166 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
                        TABLE 167 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
                        TABLE 168 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
                        TABLE 169 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
                        TABLE 170 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
             10.5.2 BRAZIL
                        10.5.2.1 Free and universal healthcare services to boost market
                                      TABLE 171 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 172 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.5.3 ARGENTINA
                        10.5.3.1 Rapid urbanization and increase in import of drugs to fuel market
                                      TABLE 173 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 174 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.5.4 REST OF SOUTH AMERICA
                        TABLE 175 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 176 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 RECESSION IMPACT
                        TABLE 177 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
                        TABLE 178 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
                        TABLE 179 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
                        TABLE 181 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
                        TABLE 182 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
                        TABLE 183 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
                        TABLE 184 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
                        TABLE 185 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
                        TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
                        TABLE 187 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
                        TABLE 188 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
             10.6.2 GCC
                        10.6.2.1 UAE
                                     10.6.2.1.1 Increasing initiatives for domestic pharmaceutical production to drive market
                                                      TABLE 189 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                                      TABLE 190 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
                        10.6.2.2 Saudi Arabia
                                     10.6.2.2.1 More comprehensive access to healthcare services to fuel demand for pharmaceuticals
                                                      TABLE 191 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                                      TABLE 192 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
                        10.6.2.3 Rest of GCC
             10.6.3 SOUTH AFRICA
                        10.6.3.1 Gradual rise in use of generic drugs to drive market
                                      TABLE 193 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                                      TABLE 194 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
             10.6.4 REST OF MIDDLE EAST & AFRICA
                        TABLE 195 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
                        TABLE 196 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 221)
     11.1 OVERVIEW 
     11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 
             FIGURE 41 OVERVIEW OF KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2019 AND 2023
     11.3 REVENUE ANALYSIS 
             FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES (2020–2022)
     11.4 MARKET SHARE ANALYSIS 
             11.4.1 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2022
                        FIGURE 43 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2022
             11.4.2 MARKET SHARE OF KEY PLAYERS, 2022
                        FIGURE 44 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2022)
                        TABLE 197 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 45 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX, 2022
             11.5.5 COMPANY FOOTPRINT
                        TABLE 198 PACKAGING TYPE FOOTPRINT (25 COMPANIES)
                        TABLE 199 DRUG DELIVERY MODE FOOTPRINT (25 COMPANIES)
                        TABLE 200 REGION FOOTPRINT (25 COMPANIES)
                        TABLE 201 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
     11.6 START-UP/SME EVALUATION MATRIX 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 RESPONSIVE COMPANIES
             11.6.3 DYNAMIC COMPANIES
             11.6.4 STARTING BLOCKS
                        FIGURE 46 PHARMACEUTICAL PACKAGING MARKET: START-UP/SME EVALUATION MATRIX, 2022
             11.6.5 COMPETITIVE BENCHMARKING
                        TABLE 202 PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES (25 COMPANIES)
     11.7 COMPETITIVE SCENARIO AND TRENDS 
             11.7.1 PRODUCT LAUNCHES/DEVELOPMENTS
                        TABLE 203 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES/ DEVELOPMENTS, 2019–2023
             11.7.2 DEALS
                        TABLE 204 PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2023
             11.7.3 OTHER DEVELOPMENTS
                        TABLE 205 PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS, 2019–2023 241
 
12 COMPANY PROFILES (Page No. - 246)
(Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats) * 
     12.1 KEY PLAYERS 
             12.1.1 BERRY GLOBAL INC.
                        TABLE 206 BERRY GLOBAL INC.: COMPANY OVERVIEW
                        FIGURE 47 BERRY GLOBAL INC.: COMPANY SNAPSHOT
                        TABLE 207 BERRY GLOBAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 208 BERRY GLOBAL INC.: PRODUCT LAUNCHES
                        TABLE 209 BERRY GLOBAL INC.: DEALS
                        TABLE 210 BERRY GLOBAL INC.: OTHER DEVELOPMENTS
             12.1.2 GERRESHEIMER AG
                        TABLE 211 GERRESHEIMER AG: COMPANY OVERVIEW
                        FIGURE 48 GERRESHEIMER AG: COMPANY SNAPSHOT
                        TABLE 212 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 213 GERRESHEIMER AG: PRODUCT LAUNCHES
                        TABLE 214 GERRESHEIMER AG: DEALS
                        TABLE 215 GERRESHEIMER AG: OTHER DEVELOPMENTS
             12.1.3 AMCOR PLC
                        TABLE 216 AMCOR PLC: COMPANY OVERVIEW
                        FIGURE 49 AMCOR PLC: COMPANY SNAPSHOT
                        TABLE 217 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 218 AMCOR PLC: PRODUCT LAUNCHES
                        TABLE 219 AMCOR PLC: DEALS
                        TABLE 220 AMCOR PLC: OTHER DEVELOPMENTS
             12.1.4 SCHOTT AG
                        TABLE 221 SCHOTT AG: COMPANY OVERVIEW
                        FIGURE 50 SCHOTT AG: COMPANY SNAPSHOT
                        TABLE 222 SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 223 SCHOTT AG: PRODUCT LAUNCHES
                        TABLE 224 SCHOTT AG: DEALS
                        TABLE 225 SCHOTT AG: OTHER DEVELOPMENTS
             12.1.5 APTARGROUP, INC.
                        TABLE 226 APTARGROUP, INC.: COMPANY OVERVIEW
                        FIGURE 51 APTARGROUP, INC.: COMPANY SNAPSHOT
                        TABLE 227 APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 228 APTARGROUP, INC.: PRODUCT LAUNCHES
                        TABLE 229 APTARGROUP, INC.: DEALS
                        TABLE 230 APTARGROUP, INC.: OTHER DEVELOPMENTS
             12.1.6 BD
                        TABLE 231 BD: COMPANY OVERVIEW
                        FIGURE 52 BD: COMPANY SNAPSHOT
                        TABLE 232 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 233 BD: PRODUCT LAUNCHES
                        TABLE 234 BD: DEALS
                        TABLE 235 BD: OTHER DEVELOPMENTS
             12.1.7 WESTROCK COMPANY
                        TABLE 236 WESTROCK COMPANY: COMPANY OVERVIEW
                        FIGURE 53 WESTROCK COMPANY: COMPANY SNAPSHOT
                        TABLE 237 WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 238 WESTROCK COMPANY: DEALS
                        TABLE 239 WESTROCK COMPANY: OTHER DEVELOPMENTS
             12.1.8 NIPRO CORPORATION
                        TABLE 240 NIPRO CORPORATION: COMPANY OVERVIEW
                        FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT
                        TABLE 241 NIPRO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 242 NIPRO CORPORATION: PRODUCT LAUNCHES
                        TABLE 243 NIPRO CORPORATION: DEALS
             12.1.9 CATALENT, INC.
                        TABLE 244 CATALENT, INC.: COMPANY OVERVIEW
                        FIGURE 55 CATALENT, INC.: COMPANY SNAPSHOT
                        TABLE 245 CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 246 CATALENT, INC.: DEALS
                        TABLE 247 CATALENT, INC.: OTHER DEVELOPMENTS
             12.1.10 SEALED AIR
                        TABLE 248 SEALED AIR: COMPANY OVERVIEW
                        FIGURE 56 SEALED AIR: COMPANY SNAPSHOT
                        TABLE 249 SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 250 SEALED AIR: PRODUCT LAUNCHES
                        TABLE 251 SEALED AIR: DEALS
             12.1.11 WEST PHARMACEUTICAL SERVICES, INC.
                        TABLE 252 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
                        FIGURE 57 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
                        TABLE 253 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 254 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES
                        TABLE 255 WEST PHARMACEUTICAL SERVICES, INC.: OTHER DEVELOPMENTS
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
     12.2 OTHER PLAYERS 
             12.2.1 ALPLA
                        TABLE 256 ALPLA: COMPANY OVERVIEW
             12.2.2 ARDAGH GROUP S.A.
                        TABLE 257 ARDAGH GROUP S.A.: COMPANY OVERVIEW
             12.2.3 CCL INDUSTRIES INC.
                        TABLE 258 CCL INDUSTRIES INC.: COMPANY OVERVIEW
             12.2.4 FRANK NOE
                        TABLE 259 FRANK NOE: COMPANY OVERVIEW
             12.2.5 GAPLAST GMBH
                        TABLE 260 GAPLAST GMBH: COMPANY OVERVIEW
             12.2.6 LONZA
                        TABLE 261 LONZA: COMPANY OVERVIEW
             12.2.7 MONDI GROUP
                        TABLE 262 MONDI GROUP: COMPANY OVERVIEW
             12.2.8 NOLATO AB
                        TABLE 263 NOLATO AB: COMPANY OVERVIEW
             12.2.9 ORIGIN PHARMA PACKAGING
                        TABLE 264 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
             12.2.10 COMAR
                        TABLE 265 COMAR: COMPANY OVERVIEW
             12.2.11 BILCARE LIMITED
                        TABLE 266 BILCARE LIMITED: COMPANY OVERVIEW
             12.2.12 SGD PHARMA
                        TABLE 267 SGD PHARMA: COMPANY OVERVIEW
             12.2.13 SILGAN HOLDINGS INC.
                        TABLE 268 SILGAN HOLDINGS INC.: COMPANY OVERVIEW
             12.2.14 VETTER PHARMA INTERNATIONAL GMBH
                        TABLE 269 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW
 
13 APPENDIX (Page No. - 302)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current market size for pharmaceutical packaging. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.  Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation methodologies were used to estimate the market size of segments and sub-segments.

Secondary Research

In the secondary research process, various sources have been referred to for identifying and collecting information for this study. The secondary sources include annual reports, press releases, and investor presentations of companies; white papers, journals, and certified publications; and articles from recognized authors, directories, and databases. Secondary data has been collected and analyzed to arrive at the overall market size, which is further validated by primary research. Secondary research has been used to obtain key information about the value chain of the industry, the monetary chain of the market, the total pool of key players, market classification, and segmentation according to industry trends to the bottom-most level and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The pharmaceutical packaging market involves a variety of stakeholders across the value chain, including raw material suppliers, manufacturers, and end-users. For this study, both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information. Key opinion leaders from various end-use sectors were interviewed from the demand side, while manufacturers and associations were interviewed from the supply side.

Primary interviews helped to gather insights on market statistics, revenue data, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to identify trends related to grade, application, end-use industries, and region. C-level executives from the demand side, such as CIOs, CTOs, and CSOs, were interviewed to understand their perspective on suppliers, products, and component providers, which will affect the overall market.

Breakdown of primary interviews

Pharmaceutical Packaging Market Size, and Share

Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022 available in the public domain, product portfolios, and geographical presence.

Other designations include sales representatives, production heads, and technicians.

To know about the assumptions considered for the study, download the pdf brochure

Company Name

Designation

Berry Global Inc.

Sales Manager

Gerresheimer AG

Sales Manager

Amcor PLC

Technical Sales Manager

Schott AG

Marketing Manager

AptarGroup

R&D Manager

Market Size Estimation

  • The top-down approach was used to estimate and validate the size of various submarkets for pharmaceutical packaging for each region. The research methodology used to estimate the market size included the following steps:
  • The key players in the industry have been identified through extensive secondary research.
  • The supply chain of the industry has been determined through primary and secondary research.
  • The global market was then segmented into five major regions and validated by industry experts.
  • All percentage shares, splits, and breakdowns based on product type, packaging type, drug delivery, raw material, and country were determined using secondary sources and verified through primary sources.

All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis and presented in this report.

Pharmaceutical Packaging Market: Bottum-Up Approach

Pharmaceutical Packaging Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Pharmaceutical Packaging Market: Top-Down Approach

Pharmaceutical Packaging Market Size, and Share

Source: Secondary Research, Interviews with Experts, and MarketsandMarkets Analysis

Data Triangulation

After arriving at the overall market size—using the market size estimation process explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply of pharmaceutical packaging.

Market Definition

Pharmaceutical packaging can be defined as products that are used for the packaging of medicines to prevent their contamination, provide protection from harsh environmental conditions (such as moisture, snow, and others), and ensure safety throughout their shelf life. It can be categorized into two forms—primary and secondary packaging. The layer or material in direct contact with the drug is known as primary packaging, whereas the packaging used to further cover or protect the drug is secondary packaging. The primary objective of pharmaceutical packaging is to safeguard drugs from environmental factors during storage and usage, preserve the original properties of the drugs, and ensure quality assurance. It also involves providing clear identification of trademarks and comprehensive drug descriptions.

Key Stakeholders

  • Manufacturers of pharmaceutical packaging
  • Raw Material Suppliers
  • End-use companies, pharmaceutical companies, healthcare companies
  • Traders, Distributors, and Suppliers
  • Regional Manufacturers’ Associations
  • Government and regional Agencies and Research Organizations

Objectives of the Study:

  • To analyze and forecast the pharmaceutical packaging market in terms of value and volume
  • To provide detailed information about the key factors (drivers, restraints, opportunities, and challenges) influencing the market
  • To analyze and forecast the market by type, raw material, drug delivery, packaging type, and region
  • To forecast the size of the market with respect to five regions: Asia Pacific, Europe, North America, South America, and the Middle East & Africa, along with their key countries
  • To strategically analyze micro markets1 with respect to individual trends, growth prospects, and their contribution to the overall market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders
  • Analyze competitive developments, such as mergers & acquisitions, new product launches/development, investments & expansions, and agreements & collaborations, and partnerships in the market.
  • Strategically profile key players and comprehensively analyze their market shares and core competencies.

Available Customizations:

MarketsandMarkets offers the following customizations for this market report.

  • Additional country-level analysis of the pharmaceutical packaging market
  • Profiling of additional market players (up to 3)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
CH 3482
Published ON
Jan, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback